Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Total Liabilities 2012–2025
Crescent Biopharma, Inc. annual total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Crescent Biopharma, Inc. total liabilities as of December 31, 2025: 37.3M, a 440.14% increase year-over-year.
- Crescent Biopharma, Inc. total liabilities for 2025 were 37.3M, a 440.14% increase from 2023.
- Crescent Biopharma, Inc. total liabilities for 2023 were 6.9M, a 22.28% decrease from 2022.
- Crescent Biopharma, Inc. total liabilities for 2022 were 8.9M, a 30.31% decrease from 2021.
- Crescent Biopharma, Inc. total liabilities for 2021 were 12.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crescent Biopharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $37 |
| 2023 | $7 |
| 2022 | $9 |
| 2021 | $13 |
| 2020 | $15 |
| 2016 | $7 |
| 2015 | $8 |
| 2014 | $6 |
| 2013 | $2 |
Crescent Biopharma, Inc. Total Liabilities — FAQ
Crescent Biopharma, Inc. (CBIO) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's total liabilities history?
The chart and table above show Crescent Biopharma, Inc.'s total liabilities by year and by quarter, including the growth rate.